FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3133466751> ?p ?o ?g. }

• W3133466751 endingPage "100258" @default.
• W3133466751 startingPage "100258" @default.
• W3133466751 abstract "•Abnormal liver tests are common in patients infected with SARS-Cov-2 and are associated with worse outcomes.•Comparison of abnormal liver tests in SARS-CoV-2 and influenza infected patients show similarities in relation to disease severity and worse outcomes.•Abnormal liver tests may appear later during hospitalisation in SARS-CoV-2- compared to influenza-infected patients.•Abnormal liver tests most probably reflect disease severity, rather than direct liver injury. Background & AimsAbnormal liver tests are common in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, but a possible direct role of the virus in liver injury and its association with short-term outcomes are controversial. Therefore, we aimed to compare the pattern of abnormal liver tests in patients with SARS-CoV-2 with those of patients infected with influenza, a non-hepatotropic respiratory virus, and their association with worse outcomes during hospitalisation.MethodsWe performed a retrospective cohort study of 1,737 hospitalised patients (865 with influenza and 872 with SARS-CoV-2) in a tertiary medical centre. We defined abnormal liver tests as alanine transaminase or aspartate transaminase ≥40 IU/ml at any time-point during hospitalisation.ResultsAbnormal liver tests were mild to moderate in most patients regardless of infection type, but the majority of patients with influenza had a transaminase peak earlier during hospitalisation compared with patients with SARS-CoV-2. Abnormal liver tests correlated with markers of severe disease in either influenza or SARS-CoV-2 infections, and were associated with death, occurring mainly in patients with severe liver test abnormalities (>200 IU/L) (38.7% and 60% of patients with influenza or SARS-CoV-2, respectively). In multivariate analysis, controlling for age, sex, lymphopaenia, and C-reactive protein, liver test abnormalities remained significantly associated with death for influenza (odds ratio 4.344; 95% CI 2.218–8.508) and SARS-CoV-2 (odds ratio 3.898; 95% CI 2.203–6.896). These results were confirmed upon propensity score matching.ConclusionsAbnormal liver tests during hospitalisation with SARS-CoV-2 or influenza infections are common, may differ in their time course, and reflect disease severity. They are associated with worse outcomes, mainly in patients with severe liver test abnormalities, regardless of infection type.Lay summaryCoronavirus disease 2019 (COVID-19) is a serious global health pandemic, the causative agent of which is severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Abnormal liver tests are common among SARS-CoV-2 infected patients and are often associated with worse outcomes. Herein, we compare the pattern of abnormal liver tests and their association with disease severity between 2 major non-hepatotropic respiratory viruses: SARS-CoV-2 and influenza. We show that abnormal liver tests are common in both infections, may slightly differ in their kinetics, and are associated with worse outcomes, especially in patients with severe liver test abnormalities. These results strongly suggest that abnormal liver tests in SARS-CoV-2 patients reflect disease severity, rather than a virus-mediated direct liver injury, and should be closely followed in admitted patients. Abnormal liver tests are common in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, but a possible direct role of the virus in liver injury and its association with short-term outcomes are controversial. Therefore, we aimed to compare the pattern of abnormal liver tests in patients with SARS-CoV-2 with those of patients infected with influenza, a non-hepatotropic respiratory virus, and their association with worse outcomes during hospitalisation. We performed a retrospective cohort study of 1,737 hospitalised patients (865 with influenza and 872 with SARS-CoV-2) in a tertiary medical centre. We defined abnormal liver tests as alanine transaminase or aspartate transaminase ≥40 IU/ml at any time-point during hospitalisation. Abnormal liver tests were mild to moderate in most patients regardless of infection type, but the majority of patients with influenza had a transaminase peak earlier during hospitalisation compared with patients with SARS-CoV-2. Abnormal liver tests correlated with markers of severe disease in either influenza or SARS-CoV-2 infections, and were associated with death, occurring mainly in patients with severe liver test abnormalities (>200 IU/L) (38.7% and 60% of patients with influenza or SARS-CoV-2, respectively). In multivariate analysis, controlling for age, sex, lymphopaenia, and C-reactive protein, liver test abnormalities remained significantly associated with death for influenza (odds ratio 4.344; 95% CI 2.218–8.508) and SARS-CoV-2 (odds ratio 3.898; 95% CI 2.203–6.896). These results were confirmed upon propensity score matching. Abnormal liver tests during hospitalisation with SARS-CoV-2 or influenza infections are common, may differ in their time course, and reflect disease severity. They are associated with worse outcomes, mainly in patients with severe liver test abnormalities, regardless of infection type." @default.
• W3133466751 created "2021-03-01" @default.
• W3133466751 creator A5005298676 @default.
• W3133466751 creator A5023381842 @default.
• W3133466751 creator A5038008488 @default.
• W3133466751 creator A5043867784 @default.
• W3133466751 creator A5044217033 @default.
• W3133466751 creator A5074737362 @default.
• W3133466751 date "2021-06-01" @default.
• W3133466751 modified "2023-09-27" @default.
• W3133466751 title "Abnormal liver tests in patients with SARS-CoV-2 or influenza – prognostic similarities and temporal disparities" @default.
• W3133466751 cites W1569943635 @default.
• W3133466751 cites W2019932229 @default.
• W3133466751 cites W2090258227 @default.
• W3133466751 cites W2115692333 @default.
• W3133466751 cites W2123559384 @default.
• W3133466751 cites W2797111183 @default.
• W3133466751 cites W3001118548 @default.
• W3133466751 cites W3002108456 @default.
• W3133466751 cites W3008827533 @default.
• W3133466751 cites W3009885589 @default.
• W3133466751 cites W3012849736 @default.
• W3133466751 cites W3013384091 @default.
• W3133466751 cites W3016706298 @default.
• W3133466751 cites W3022778033 @default.
• W3133466751 cites W3023986730 @default.
• W3133466751 cites W3025587545 @default.
• W3133466751 cites W3026967842 @default.
• W3133466751 cites W3027470143 @default.
• W3133466751 cites W3029397768 @default.
• W3133466751 cites W3030272834 @default.
• W3133466751 cites W3031626084 @default.
• W3133466751 cites W3032031508 @default.
• W3133466751 cites W3039510633 @default.
• W3133466751 cites W3044536727 @default.
• W3133466751 cites W3045742311 @default.
• W3133466751 doi "https://doi.org/10.1016/j.jhepr.2021.100258" @default.
• W3133466751 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7902222" @default.
• W3133466751 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33644724" @default.
• W3133466751 hasPublicationYear "2021" @default.
• W3133466751 type Work @default.
• W3133466751 sameAs 3133466751 @default.
• W3133466751 citedByCount "12" @default.
• W3133466751 countsByYear W31334667512022 @default.
• W3133466751 countsByYear W31334667512023 @default.
• W3133466751 crossrefType "journal-article" @default.
• W3133466751 hasAuthorship W3133466751A5005298676 @default.
• W3133466751 hasAuthorship W3133466751A5023381842 @default.
• W3133466751 hasAuthorship W3133466751A5038008488 @default.
• W3133466751 hasAuthorship W3133466751A5043867784 @default.
• W3133466751 hasAuthorship W3133466751A5044217033 @default.
• W3133466751 hasAuthorship W3133466751A5074737362 @default.
• W3133466751 hasBestOaLocation W31334667511 @default.
• W3133466751 hasConcept C126322002 @default.
• W3133466751 hasConcept C160160445 @default.
• W3133466751 hasConcept C167135981 @default.
• W3133466751 hasConcept C181199279 @default.
• W3133466751 hasConcept C2776637226 @default.
• W3133466751 hasConcept C2776877979 @default.
• W3133466751 hasConcept C2777075537 @default.
• W3133466751 hasConcept C2778606649 @default.
• W3133466751 hasConcept C2779134260 @default.
• W3133466751 hasConcept C2779679107 @default.
• W3133466751 hasConcept C2780567839 @default.
• W3133466751 hasConcept C30036603 @default.
• W3133466751 hasConcept C512861765 @default.
• W3133466751 hasConcept C55493867 @default.
• W3133466751 hasConcept C71924100 @default.
• W3133466751 hasConcept C86803240 @default.
• W3133466751 hasConcept C90924648 @default.
• W3133466751 hasConceptScore W3133466751C126322002 @default.
• W3133466751 hasConceptScore W3133466751C160160445 @default.
• W3133466751 hasConceptScore W3133466751C167135981 @default.
• W3133466751 hasConceptScore W3133466751C181199279 @default.
• W3133466751 hasConceptScore W3133466751C2776637226 @default.
• W3133466751 hasConceptScore W3133466751C2776877979 @default.
• W3133466751 hasConceptScore W3133466751C2777075537 @default.
• W3133466751 hasConceptScore W3133466751C2778606649 @default.
• W3133466751 hasConceptScore W3133466751C2779134260 @default.
• W3133466751 hasConceptScore W3133466751C2779679107 @default.
• W3133466751 hasConceptScore W3133466751C2780567839 @default.
• W3133466751 hasConceptScore W3133466751C30036603 @default.
• W3133466751 hasConceptScore W3133466751C512861765 @default.
• W3133466751 hasConceptScore W3133466751C55493867 @default.
• W3133466751 hasConceptScore W3133466751C71924100 @default.
• W3133466751 hasConceptScore W3133466751C86803240 @default.
• W3133466751 hasConceptScore W3133466751C90924648 @default.
• W3133466751 hasIssue "3" @default.
• W3133466751 hasLocation W31334667511 @default.
• W3133466751 hasLocation W31334667512 @default.
• W3133466751 hasLocation W31334667513 @default.
• W3133466751 hasOpenAccess W3133466751 @default.
• W3133466751 hasPrimaryLocation W31334667511 @default.
• W3133466751 hasRelatedWork W130231721 @default.
• W3133466751 hasRelatedWork W1653224471 @default.
• W3133466751 hasRelatedWork W2372320496 @default.
• W3133466751 hasRelatedWork W2380048095 @default.
• W3133466751 hasRelatedWork W2558360119 @default.

• next